Houston, TX, United States of America

Mohammad Shahnawaz

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mohammad Shahnawaz in Neurological Diagnostics

Introduction: Mohammad Shahnawaz, an accomplished inventor based in Houston, TX, has made significant strides in the field of neurological diagnostics. With a total of four patents to his name, Shahnawaz's work is pivotal in distinguishing complex neurological disorders, thereby improving patient outcomes.

Latest Patents: Among his latest innovations is a groundbreaking method for discriminating Parkinson's disease from multiple system atrophy using alpha-synuclein PMCA. This method allows for the accurate diagnosis of these disorders in patients who present symptoms of both conditions. The process involves several steps: initially, a biological sample containing misfolded alpha-synuclein protein is contacted with a specific pre-incubation mixture. Following this, the mixture undergoes multiple incubation cycles to create misfolded alpha-synuclein aggregates, which are then detected through fluorescence emission intensity, enabling the diagnosis of either Parkinson’s disease or multiple system atrophy.

Furthermore, Shahnawaz has developed methods and kits for amplifying and detecting misfolded tau protein, crucial for diagnosing tauopathies such as Alzheimer’s Disease and Progressive Supranuclear Palsy. These innovations are instrumental in enhancing the understanding and management of neurodegenerative diseases.

Career Highlights: Throughout his career, Mohammad Shahnawaz has collaborated with key organizations, notably Amprion, Inc. and the University of Texas System. His work has garnered attention for its potential impact on neurodiagnostics and therapeutic approaches.

Collaborations: Noteworthy collaborations have included contributions alongside esteemed professionals like Claudio Soto Jara and Russell M. Lebovitz. These partnerships underscore Shahnawaz's commitment to leveraging collective expertise in advancing healthcare solutions.

Conclusion: Mohammad Shahnawaz's contributions to the field of neurological diagnostics exemplify the profound impact of innovation on healthcare. Through his patents and collaborative efforts, he continues to pave the way for enhanced diagnostic methodologies that hold the promise of better patient care and understanding of neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…